Document is current

Article History

Received: 11 June 2025

Accepted: 6 October 2025

First Online: 7 November 2025

Declarations

:

: R ter Heine reports research funding from AMGEN and Stichting Treatmeds and fees received for acting as an advisory board member for Samsung Bioepis. LEL Hendriks reports research funding from Roche Genentech, AstraZeneca, Boehringer Ingelheim, Takeda, Merck, Pfizer, Novartis, Gilead, speaker fees paid by AstraZeneca, Bayer, Lilly, MSD, high5oncology, Takeda, Janssen, GSK, Sanofi, Pfizer, Medtalks, Benecke, VJOncology, Medimix, advisory board fees for Abbvie, Amgen, Anhearth, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Daiichi, GSK, Janssen, Lilly, Merck, MSD, Novartis, Pfizer, Pierre Fabre, Roche, Sanofi, Summit Therapeutics, Takeda and and reports being member of Dutch guidelines on NSCLC, brain metastases and leptomeningeal metastases, ESMO guidelines on metastatic NSCLC, non-metastatic NSCLC and SCLC. WH Van Geffen reports a leadership role with the European Respiratory Society and NVALT (Dutch Society of Respiratory Physicians); and there have been trials run by his department funded by Roche and MSD. AJ de Langen reports research grants from BMS, MSD, Boehringer, AstraZeneca and Daiichi Sankyo; non-financial interests, other from Merck Serono, Roche. MM van den Heuvel reports research funding from Roche Genentech, AstraZeneca, BMS,Boehringer Ingelheim, Merck, Novartis, Pamgene, Pfizer, Roche diagnostics, Stichting Treatmeds and Takeda and fees for participation in advisory boards for Abbvie, Amgen, AstraZeneca, Bayer, BMS, Boehringer Ingelheim, Janssen, Lilly, Merck, MSD, Novartis, Pfizer, Roche, Sanofi and Takeda. Lastly he was local investigator for studies sponsored by AstraZeneca, BMS, GSK, Novartis, Merck, Roche, Takeda, Mirati, Abbvie, MSD, Merck, Amgen, Boehringer Ingelheim and Pfizer. AJ van der Wekken reports research grants from AstraZeneca, Boehringer Ingelheim, Pfizer, Roche, and Takeda; consulting fees from AstraZeneca, Janssen, Lilly, Roche, and Takeda; payments or honoraria from AstraZeneca, BMS, Lilly, Pfizer, and Roche all paid to the institution and outside the submitted work.